{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:51:32Z","timestamp":1788871892541,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Urological Research Institute"},{"name":"Gester Foundation"},{"name":"Recordati"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.ejphar.2014.09.030","type":"journal-article","created":{"date-parts":[[2014,9,23]],"date-time":"2014-09-23T07:03:52Z","timestamp":1411455832000},"page":"42-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Silodosin and tadalafil have synergistic inhibitory effects on nerve-mediated contractions of human and rat isolated prostates"],"prefix":"10.1016","volume":"744","author":[{"given":"Roberta","family":"Buono","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Briganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Freschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"La Croce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3084-2458","authenticated-orcid":false,"given":"Marco","family":"Moschini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Benigni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Castiglione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Montorsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petter","family":"Hedlund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2014.09.030_bib1","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/nau.20999","article-title":"Tadalafil for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: pathophysiology and mechanism(s) of action","volume":"30","author":"Andersson","year":"2011","journal-title":"Neurourol. Urodyn."},{"key":"10.1016\/j.ejphar.2014.09.030_bib2","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/ncpuro0836","article-title":"Pharmacology of alpha1-adrenoceptor antagonists in the lower urinary tract and central nervous system","volume":"4","author":"Andersson","year":"2007","journal-title":"Nat. Clin. Pract. Urol."},{"key":"10.1016\/j.ejphar.2014.09.030_bib3","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1111\/j.1743-6109.2012.02821.x","article-title":"Tadalafil enhances the inhibitory effects of tamsulosin on neurogenic contractions of human prostate and bladder neck","volume":"9","author":"Angulo","year":"2012","journal-title":"J. Sex. Med."},{"key":"10.1016\/j.ejphar.2014.09.030_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1097-0045(19970915)33:1<1::AID-PROS1>3.0.CO;2-P","article-title":"Distribution of nitric oxide synthase implies a regulation of circulation, smooth muscle tone, and secretory function in the human prostate by nitric oxide","volume":"33","author":"Bloch","year":"1997","journal-title":"Prostate"},{"issue":"28","key":"10.1016\/j.ejphar.2014.09.030_bib5","doi-asserted-by":"crossref","first-page":"28998","DOI":"10.1074\/jbc.M404259200","article-title":"Actions downstream of cyclic GMP\/protein kinase G can reverse protein kinase C-mediated phosphorylation of CPI-17 and Ca(2+) sensitization in smooth muscle","volume":"279","author":"Bonnevier","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2014.09.030_bib6","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.urology.2009.09.093","article-title":"Effects of tadalafil on lower urinary tract symptoms secondary to benign prostatic hyperplasia in men with or without erectile dysfunction","volume":"75","author":"Broderick","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.ejphar.2014.09.030_bib7","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose\u2013effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"Chou","year":"1984","journal-title":"Adv. Enzym. Regul."},{"key":"10.1016\/j.ejphar.2014.09.030_bib8","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrn2401","article-title":"The neural control of micturition","volume":"9","author":"Fowler","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ejphar.2014.09.030_bib9","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.eururo.2012.02.033","article-title":"A systematic review and meta-analysis on the use of phosphodiesterase 5 inhibitors alone or in combination with \u03b1-blockers for lower urinary tract symptoms due to benign prostatic hyperplasia","volume":"61","author":"Gacci","year":"2012","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ejphar.2014.09.030_bib10","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.eururo.2012.09.006","article-title":"The mechanism of action of phosphodiesterase type 5 inhibitors in the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia","volume":"63","author":"Giuliano","year":"2013","journal-title":"Eur. Urol."},{"issue":"2","key":"10.1016\/j.ejphar.2014.09.030_bib11","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/bph.12143","article-title":"Ca2+ -activated K+ channel (KCa) stimulation improves relaxant capacity of PDE5 inhibitors in human penile arteries and recovers the reduced efficacy of PDE5 inhibition in diabetic erectile dysfunction","volume":"169","author":"Gonz\u00e1lez-Corrochano","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"2 Pt 1","key":"10.1016\/j.ejphar.2014.09.030_bib12","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/ajh\/4.2.173","article-title":"Cyclic GMP modulates release of norepinephrine from adrenergic nerves innervating canine arteries","volume":"4","author":"Greenberg","year":"1991","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.ejphar.2014.09.030_bib13","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s00345-005-0019-1","article-title":"Nitric oxide\/cGMP-mediated effects in the outflow region of the lower urinary tract-is there a basis for pharmacological targeting of cGMP?","volume":"23","author":"Hedlund","year":"2005","journal-title":"World J. Urol."},{"key":"10.1016\/j.ejphar.2014.09.030_bib14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0165-1838(96)00139-7","article-title":"Heme oxygenase and NO-synthase in the human prostate-relation to adrenergic, cholinergic and peptide-containing nerves","volume":"63","author":"Hedlund","year":"1997","journal-title":"J. Auton. Nerv. Syst."},{"key":"10.1016\/j.ejphar.2014.09.030_bib15","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.urology.2005.12.002","article-title":"In vitro functional responses of isolated normal human prostatic tissue to compounds interacting with the cyclic guanosine monophosphate pathway","volume":"67","author":"Kedia","year":"2006","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.ejphar.2014.09.030_bib16","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ejphar.2006.05.005","article-title":"Mechanisms of direct relaxant effect of sildenafil, tadalafil and vardenafil on corpus cavernosum","volume":"541","author":"Lau","year":"2006","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.ejphar.2014.09.030_bib17","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0031-6997(24)01457-1","article-title":"Guanylyl cyclases and signaling by cyclic GMP","volume":"52","author":"Lucas","year":"2000","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2014.09.030_bib18","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.juro.2011.01.074","article-title":"Update on AUA guideline on the management of benign prostatic hyperplasia","volume":"185","author":"McVary","year":"2011","journal-title":"J. Urol."},{"key":"10.1016\/j.ejphar.2014.09.030_bib19","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1111\/j.1743-6109.2011.02416.x","article-title":"Phosphodiesterase type 5 expression in human and rat lower urinary tract tissues and the effect of tadalafil on prostate gland oxygenation in spontaneously hypertensive rats","volume":"8","author":"Morelli","year":"2011","journal-title":"J. Sex. Med."},{"key":"10.1016\/j.ejphar.2014.09.030_bib20","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0014-2999(97)01270-3","article-title":"Characterisation of excitatory and inhibitory transmitter systems in prostate glands of rats, guinea pigs, rabbits and pigs","volume":"337","author":"Najbar-Kaszkiel","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.09.030_bib21","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.eururo.2012.01.013","article-title":"Monotherapy with tadalafil or tamsulosin similarly improved lower urinary tract symptoms suggestive of benign prostatic hyperplasia in an international, randomised, parallel, placebo-controlled clinical trial","volume":"61","author":"Oelke","year":"2012","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ejphar.2014.09.030_bib22","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.eururo.2009.04.039","article-title":"Combination of alfuzosin and tadalafil exerts an additive relaxant effect on human detrusor and prostatic tissues in vitro","volume":"57","author":"Oger","year":"2010","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ejphar.2014.09.030_bib23","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/j.1743-6109.2008.01138.x","article-title":"Combination of doxazosin and sildenafil exerts an additive relaxing effect compared with each compound alone on human cavernosal and prostatic tissue","volume":"6","author":"Oger","year":"2009","journal-title":"J. Sex. Med."},{"key":"10.1016\/j.ejphar.2014.09.030_bib24","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/(SICI)1097-0045(19980501)35:2<102::AID-PROS3>3.0.CO;2-L","article-title":"Testosterone-induced prostatic growth in the rat causes bladder overactivity unrelated to detrusor hypertrophy","volume":"35","author":"Pandita","year":"1998","journal-title":"Prostate"},{"issue":"4","key":"10.1016\/j.ejphar.2014.09.030_bib25","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1046\/j.1365-2680.2000.00195.x","article-title":"The autonomic and sensory innervation of the smooth muscle of the prostate gland: a review of pharmacological and histological studies","volume":"20","author":"Pennefather","year":"2000","journal-title":"J. Auton. Pharmacol."},{"key":"10.1016\/j.ejphar.2014.09.030_bib26","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.eururo.2011.08.005","article-title":"Efficacy and safety of tadalafil once daily in the treatment of men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: results of an international randomized, double-blind, placebo-controlled trial","volume":"60","author":"Porst","year":"2011","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ejphar.2014.09.030_bib27","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.eursup.2011.08.001","article-title":"Silodosin from bench to bedside: selectivity, safety, and sustained efficacy","volume":"10","author":"Russo","year":"2011","journal-title":"Eur. Urol. Suppl."},{"issue":"3","key":"10.1016\/j.ejphar.2014.09.030_bib28","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1006\/bbrc.2000.4194","article-title":"cGMP-dependent protein kinase phosphorylates and inactivates RhoA","volume":"280","author":"Sawada","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2014.09.030_bib29","doi-asserted-by":"crossref","first-page":"4962","DOI":"10.1002\/jps.21789","article-title":"No clinically relevant pharmacokinetic and safety interactions of ambrisentan in combination with tadalafil in healthy volunteers","volume":"98","author":"Spence","year":"2009","journal-title":"J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.ejphar.2014.09.030_bib30","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00345-003-0394-4","article-title":"Interactions between cGMP- and cAMP-pathways are involved in the regulation of penile smooth muscle tone","volume":"22","author":"Uckert","year":"2004","journal-title":"World J. Urol."},{"key":"10.1016\/j.ejphar.2014.09.030_bib31","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1016\/S0022-5347(05)65621-2","article-title":"Characterization and functional relevance of cyclic nucleotide phosphodiesterase isoenzymes of the human prostate","volume":"166","author":"Uckert","year":"2001","journal-title":"J. Urol."},{"key":"10.1016\/j.ejphar.2014.09.030_bib32","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.eururo.2007.02.004","article-title":"Immunohistochemical distribution of cyclic GMP-dependent protein kinase-1 in human prostate tissue","volume":"52","author":"Waldkirch","year":"2007","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ejphar.2014.09.030_bib33","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1111\/j.1743-6109.2009.01301.x","article-title":"Safety, efficacy, and pharmacokinetic overview of low-dose daily administration of tadalafil","volume":"6203","author":"Wrishko","year":"2009","journal-title":"J. Sex. Med."},{"key":"10.1016\/j.ejphar.2014.09.030_bib34","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/pcan.2012.36","article-title":"A meta-analysis of efficacy and safety of the new \u03b1(1A)-adrenoceptor-selective antagonist silodosin for treating lower urinary tract symptoms associated with BPH","volume":"16","author":"Wu","year":"2013","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.ejphar.2014.09.030_bib35","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.lfs.2007.05.004","article-title":"Effects of doxazosin on blood flow and mRNA expression of nitric oxide synthase in the spontaneously hypertensive rat genitourinary tract","volume":"81","author":"Yono","year":"2007","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2014.09.030_bib36","doi-asserted-by":"crossref","first-page":"3724","DOI":"10.1016\/j.jchromb.2009.08.025","article-title":"Determination of silodosin in human plasma by liquid chromatography-tandem mass spectrometry","volume":"877","author":"Zhao","year":"2009","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299914006827?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299914006827?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:03:33Z","timestamp":1762142613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299914006827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":36,"alternative-id":["S0014299914006827"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2014.09.030","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Silodosin and tadalafil have synergistic inhibitory effects on nerve-mediated contractions of human and rat isolated prostates","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2014.09.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}